We are pleased to announce the Green Flag Gala on Thursday July 14th, 2016!
The Green Flag Gala is the premiere evening to rev up for the Honda Indy Toronto. The evening will feature a live auction, live band, drink… Continue reading
WMFC Member was featured in the QEII Time – The Chronicle. The article discusses the support he has received from the QEII Hematology Clinic.
The Waldenstrom’s Macroglobulinemia Foundation of Canada would like to extend a sincere thank you to Bert Visheau, a Board of Director member since 2003, for his dedication and support to the WMFC. Bert has stepped down after… Continue reading
Treatment options are limited for patients with Waldenstrom’s macroglobulinemia (WM), says Morie A. Gertz, MD. Combination therapies offer a potential solution, but the rarity of the disease is an obstacle. The disease occurs in roughly 4 patients per million, per… Continue reading
IMBRUVICA® is an oral, once-daily, single-agent therapy associated with a durable response in patients with this rare B-cell lymphoma
TORONTO, May 12, 2016 /CNW/ – Janssen Inc. announced today that Health Canada has issued… Continue reading
Shelby Bell Knowlton is undertaking a Tough Mudder competition on June 18th in Whistler, BC. She will be donating 100% of donations to the WMFC. We are so very appreciative of this courageous father/daughter team and invite you to support… Continue reading
If you have Waldenstrom’s Macroglobulinemia (WM) or you are a caregiver of a patient with WM, you can help by completing the surveys.
Lymphoma Canada, in partnership with the Canadian Organization… Continue reading
April 4, 2016 – We are pleased to announce that Health Canada has approved Ibrutinib for WM patients in Canada. The decision was based on sponsored study data. Information has yet to be released on the funding of the… Continue reading